EFFICACY AND IMPROVED HEALTH-RELATED QUALITY OF LIFE AFTER 52-WEEKS OF MIRIKIZUMAB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: AN UPDATE FROM A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY

Marc Ferrante  1     William Sandborn  2     Bal R Bandhari  3     Geert D’Haens  4     Brian G. Feagan  5     Michael Durante  6     Vipin Arora  7     Jay Tuttle     April Naegeli    
1 Universitair Ziekenhuizen Leuven,Leuven,Belgium
2 University California San Diego,La Jolla,United States
3 Delta Research Partners,Bastrop,United States
4 Amsterdam University Medical Centers,Amsterdam,Netherlands
5 Western University,London,Canada
6 Eli Lilly and Company,Indianapolis,United States
7 Eli Lilly and Company,Indianapolis,Unit

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing